OTC

Strength

2; 10; 5 mg/10mL; mg/10mL; mg/10mL

NDC

70677104401

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Last Updated

4/22/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

9/3/2023

Pharmacological Classes

Adrenergic alpha1-Agonists
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

+38.4%

3M

+78.1%

6M

+164.7%

1Y

+186.7%

3Y

N/A

5Y

N/A

All

+216.4%